EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MS.
Gisella GuerreraSerena RuggieriMario PicozzaEleonora PirasFrancesca GarganoRoberta PlacidoClaudio GasperiniMarco SalvettiMaria Chiara BuscarinuLuca BattistiniGiovanna BorsellinoDaniela Francesca AngeliniPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)
GA therapy acts as a disease-modifying therapy restoring homeostasis in the immune system, including anti-EBV responses.